LNTH Lantheus Holdings Inc.
As of 3:59:00 PM ET · 1 h old· Couldn’t refresh just now; showing the last price
Loading chart…
- Open
- $100.52
- Previous close
- $100.61
- Day range
- 100.52 – 101.11
- 52-week range
- 50.16 – 111.86
- Volume
- 25.3K
- Avg volume (3M)
- 1.1M
- Market cap
- $6.6B
- P/E (TTM)
- 24.31
- EPS (TTM)
- $4.13
- Beta
- 0.03
- Dividend yield
- 0.00%
- Next earnings
- —
- Ex-dividend
- —
- Sector
- Healthcare
About Lantheus Holdings Inc.
Lantheus Holdings Inc. is a radiopharmaceutical-focused healthcare company that develops, manufactures, and commercializes diagnostic and therapeutic products used to help clinicians detect, localize, and monitor disease. Its portfolio centers on precision diagnostics and nuclear medicine solutions for oncology, cardiology, and neurology, with products designed to support imaging-based diagnosis and patient management across hospitals, clinics, and other healthcare settings. The company’s current business also includes radiotherapeutics and strategic partnerships that complement its core imaging franchise. Lantheus Holdings Inc. serves a global medical market where advanced diagnostic agents play an important role in guiding treatment decisions and improving disease visibility in clinical practice. Headquartered in Bedford, Massachusetts, Lantheus Holdings Inc. operates as a specialized provider in molecular imaging and related healthcare technologies.
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Aug 6, 2026(after close) | $1.30 | $1.55 | +19.2% |
| Jul 8, 2026(after close) | $0.04 | $0.05 | +25.0% |
| May 7, 2026(after close) | $1.23 | $1.46 | +18.7% |
| Feb 26, 2026(after close) | $1.17 | $1.67 | +42.7% |
LNTH doesn’t pay a dividend.
LNTH news and filings
Loading filings…
Filings from SEC EDGAR.